Exploring mechanistic links between extracellular branched-chain amino acids and muscle insulin resistance: an in vitro approach
- 1 December 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 319 (6) , C1151-C1157
Abstract
Branched-chain amino acids (BCAAs) are essential for critical metabolic processes; however, recent studies have associated elevated plasma BCAA levels with increased risk of insulin resistance. Using skeletal muscle cells, we aimed to determine whether continued exposure of high extracellular BCAA would result in impaired insulin signaling and whether the compound sodium phenylbutyrate (PB), which induces BCAA metabolism, would lower extracellular BCAA, thereby alleviating their potentially inhibitory effects on insulin-mediated signaling. Prolonged exposure of elevated BCAA to cells resulted in impaired insulin receptor substrate 1/AKT signaling and insulin-stimulated glycogen synthesis. PB significantly reduced media BCAA and branched-chain keto acid concentrations and increased phosphorylation of AKT [+2.0 ± 0.1-fold; P < 0.001 versus without (−)PB] and AS160 (+3.2 ± 0.2-fold; P < 0.001 versus −PB); however, insulin-stimulated glycogen synthesis was further reduced upon PB treatment. Continued exposure of high BCAA resulted in impaired intracellular insulin signaling and glycogen synthesis, and while forcing BCAA catabolism using PB resulted in increases in proteins important for regulating glucose uptake, PB did not prevent the impairments in glycogen synthesis with BCAA exposure.Keywords
Funding Information
- Medical Research Council (MR/P021220/1)
This publication has 31 references indexed in Scilit:
- Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino AcidsNutrients, 2019
- Impaired Skeletal Muscle Branched-Chain Amino Acids Catabolism Contributes to Their Increased Circulating Levels in a Non-Obese Insulin-Resistant Fructose-Fed Rat ModelNutrients, 2019
- Plasma Branched-Chain Amino Acids and Risk of Incident Type 2 Diabetes: Results from the PREVEND Prospective Cohort StudyJournal of Clinical Medicine, 2018
- Effect of sodium 4-phenylbutyrate on Clenbuterol-mediated muscle growthPLOS ONE, 2018
- High dietary intake of branched‐chain amino acids is associated with an increased risk of insulin resistance in adultsJournal of Diabetes, 2017
- Restoration of metabolic health by decreased consumption of branched‐chain amino acidsThe Journal of Physiology, 2017
- Early-onset and classical forms of type 2 diabetes show impaired expression of genes involved in muscle branched-chain amino acids metabolismScientific Reports, 2017
- Branched-chain amino acids as biomarkers in diabetesCurrent Opinion in Clinical Nutrition and Metabolic Care, 2016
- Phenylbutyrate increases activity of pyruvate dehydrogenase complexOncotarget, 2013
- Phenylbutyrate therapy for maple syrup urine diseaseHuman Molecular Genetics, 2010